Featured
Health Topics
Any CategoryDiseases
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Leukemia, Lymphoid
Search Clinical Trials
Completed
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (External Link)
This is a phase I trial to assess the safety of a dose escalation of hCD40L-expressing autologous tumor cells with a fixed dose of recombinant hIL-2 gene transduced autologous leukemic …
Baylor Role:
Lead Sponsor